Cathepsin L expression is up-regulated by hypoxia in human melanoma cells: Role of its 5′-untranslated region

Biochemical Journal

Volumn 413, Issue 1, 2008, Pages 125-134

  Jean, Didier ^a   Rousselet, Nathalie ^a   Frade, Raymond ^a  

^a INSERM   (France)

Author keywords

Cathepsin L; Hypoxia; Internal ribosome entry site (IRES); Tumour progression

Indexed keywords

CELL CULTURE; CELLS; LAWS AND LEGISLATION; NUCLEIC ACIDS; ORGANIC ACIDS;

BICISTRONIC; CATHEPSIN L; CELL LINES; CYSTEINE PROTEASES; FLANKING REGIONS; HYPOXIC CONDITIONS; INTERNAL RIBOSOME ENTRY SITE (IRES); MELANOMA (MM); MELANOMA CELLS; OVER-EXPRESSION; POST-TRANSCRIPTIONAL REGULATIONS; REGULATORY SEQUENCES; REPORTER VECTORS; SPLICE VARIANTS (SV); UNTRANSLATED REGION (UTR);

DNA SEQUENCES;

CATHEPSIN L; MESSENGER RNA; CATHEPSIN; CYSTEINE PROTEINASE; DNA; ISOENZYME;

5' UNTRANSLATED REGION; ARTICLE; CELL LINE; CONTROLLED STUDY; DNA FLANKING REGION; GENE CONTROL; GENE EXPRESSION REGULATION; GENE MAPPING; GENE SEQUENCE; HUMAN; HUMAN CELL; HYPOXIA; INTERNAL RIBOSOME ENTRY SITE; MELANOMA CELL; METASTASIS; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN VARIANT; REGULATORY DNA SEQUENCE; RESTRICTION SITE; RNA SPLICING; TRANSCRIPTION REGULATION; UPREGULATION; BIOSYNTHESIS; CELL HYPOXIA; CHEMISTRY; GENETIC TRANSCRIPTION; GENETICS; MELANOMA; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

5' UNTRANSLATED REGIONS; CATHEPSINS; CELL HYPOXIA; CELL LINE, TUMOR; CYSTEINE ENDOPEPTIDASES; DNA; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; ISOENZYMES; MELANOMA; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TRANSCRIPTION, GENETIC; UP-REGULATION;

EID: 46249129706     PISSN: 02646021     EISSN: None     Source Type: Journal    
DOI: 10.1042/BJ20071255     Document Type: Article

References (39)

1. Frade, R., Rodrigues-Lima, F., Huang, S., Xie, K., Guillaume, N. and Bar-Eli, M. (1998) Procathepsin L, a proteinase that cleaves human C3 (the third component of complement), confers high tumorigenic and metastatic properties to human melanoma cells. Cancer Res. 58, 2733-2736
2. Frade, R. (1999) Structure and functions of proteases which cleave human C3 and are expressed on normal or tumor human cells: some are involved in tumorigenic and metastatic properties of human melanoma cells. Immunopharmacology 42, 39-45
3. Stabuc, B., Mrevlje, Z., Markovic, J. and Stabuc-Silih, M. (2006) Expression and prognostic significance of Cathepsin L in early cutaneous malignant melanoma. Neoplasma 53, 259-262
4. Katunuma, N., Tsuge, H., Nukatsuka, M., Asao, T. and Fukushima, M. (2002) Structure-based design of specific cathepsin inhibitors and their application to protection of bone metastases of cancer cells. Arch. Biochem. Biophys. 397, 305-311
5. Yagel, S., Warner, A. H., Nellans, H. N., Lala, P. K., Waghorne, C. and Denhardt, D. T. (1989) Suppression by cathepsin L inhibitors of the invasion of amnion membranes by murine cancer cells. Cancer Res. 49, 3553-3557
6. Yang, Z. and Cox, J. L. (2007) Cathepsin L increases invasion and migration of B16 melanoma. Cancer Cell Int. 7, 8
7. Jean, D., Bar-Eli, M., Huang, S., Xie, K., Rodrigues-Lima, F., Hermann, J. and Frade, R. (1996) A cysteine proteinase, which cleaves human C3, the third component of complement, is involved in tumorigenicity and metastasis of human melanoma. Cancer Res. 56, 254-258
8. Guillaume-Rousselet, N., Jean, D. and Frade, R. (2002) Cloning and characterization of anti-cathepsin L single chain variable fragment whose expression inhibits procathepsin L secretion in human melanoma cells. Biochem. J. 367, 219-227
9. Rousselet, N., Mills, L., Jean, D., Tellez, C., Bar-Eli, M. and Frade, R. (2004) Inhibition of tumorigenic and metastatic phenotype of human melanoma cells by anti-cathepsin L single chain variable fragment. Cancer Res. 64, 146-151
10. Jean, D., Hermann, J., Rodrigues-Lima, F., Barel, M., Balbo, M. and Frade, R. (1995) Identification on melanoma cells of p39, a cysteine proteinase that cleaves C3, the third component of complement: amino-acid-sequence identities with procathepsin L. Biochem. J. 312, 961-969
11. Jean, D., Rodrigues-Lima, F., Cassinat, B., Hermann, J., Cabane, J. and Frade, R. (1997) Co-expression and secretion of C3, the third component of complement and a C3-cleaving cysteine proteinase in a highly metastatic human melanoma cell line. Immunol. Lett. 58, 107-112
12. Jean, D., Guillaume, N. and Frade, R. (2002) Characterization of human cathepsin L promoter and identification of binding sites for NF-Y, Sp1 and Sp3 that are essential for its activity. Biochem. J. 361, 173-184
13. Jean, D., Rousselet, N. and Frade, R. (2006) Expression of cathepsin L in human tumor cells is under the control of distinct regulatory mechanisms. Oncogene 10, 1474-1484
14. Kozlowski, J. M., Hart, I. R., Fidler, I. J. and Hanna, N. (1984) A human melanoma line heterogeneous with respect to metastatic capacity in athymic nude mice. J. Natl. Cancer Inst. 72, 913-917
15. Zuker, M. (2003) Mfold web server for nucleic acid folding and hybridization prediction. Nucleic Acids Res. 31, 3406-3415
16. Komar, A. A. and Hatzoglou, M. (2005) Internal ribosome entry sites in cellular mRNAs: mystery of their existence. J. Biol. Chem. 280, 23425-23428
17. Van Eden, M. E., Byrd, M. P., Sherrill, K. W. and Lloyd, R. E. (2004) Demonstrating internal ribosome entry sites in eukaryotic mRNAs using stringent RNA test procedures. RNA 10, 720-730
18. Park, E. H., Lee, J. M., Blais, J. D., Bell, J. C. and Pelletier, J. (2005) Internal translation initiation mediated by the angiogenic factor Tie2. J. Biol. Chem. 280, 20945-20953
19. Chappell, S. A. and Mauro, V. P. (2003) The internal ribosome entry site (IRES) contained within the RNA-binding motif protein 3 (Rbm3) mRNA is composed of functionally distinct elements. J. Biol. Chem. 278, 33793-33800
20. Borman, A. M., Le Mercier, P., Girard, M. and Kean, K. M. (1997) Comparison of picornaviral IRES-driven internal initiation of translation in cultured cells of different origins. Nucleic Acids Res. 25, 925-932
21. Akiri, G., Nahari, D., Finkelstein, Y., Le, S. Y., Elroy-Stein, O. and Levi, B. Z. (1998) Regulation of vascular endothelial growth factor (VEGF) expression is mediated by internal initiation of translation and alternative initiation of transcription. Oncogene 17, 227-236
22. Stein, I., Itin, A., Einat, P., Skaliter, R., Grossman, Z. and Keshet, E. (1998) Translation of vascular endothelial growth factor mRNA by internal ribosome entry: implications for translation under hypoxia. Mol. Cell Biol. 18, 3112-3119
23. Lang, K. J., Kappel, A. and Goodall, G. J. (2002) Hypoxia-inducible factor-1alpha; mRNA contains an internal ribosome entry site that allows efficient translation during normoxia and hypoxia. Mol. Biol. Cell. 13, 1792-1801
24. Graven, K. K., Troxler, R. F., Kornfeld, H., Panchenko, M. V. and Farber, H. W. (1994) Regulation of endothelial cell glyceraldehyde-3-phosphate dehydrogenase expression by hypoxia. J. Biol. Chem. 269, 24446-24453
25. Graven, K. K., Yu, Q., Pan, D., Roncarati, J. S. and Farber, H. W. (1999) Identification of an oxygen responsive enhancer element in the glyceraldehyde-3-phosphate dehydrogenase gene. Biochim. Biophys. Acta 1447, 208-218
26. Wilkie, G. S., Dickson, K. S. and Gray, N. K. (2003) Regulation of mRNA translation by 5′-and 3′-UTR-binding factors. Trends Biochem. Sci. 28, 182-188
27. Abudula, A., Rommerskirch, W., Weber, E., Günther, D. and Wiederanders, B. (2001) Splice variants of human cathepsin L mRNA show different expression rates. Biol. Chem. 382, 1583-1591
28. Chauhan, S. S., Nicholas, C., Popescu, D. R., Fleischmann, R., Gottesman, M. M. and Troen, B. R. (1993) Cloning, genomic organization, and chromosomal localization of human cathepsin L. J. Biol. Chem. 268, 1039-1045
29. Liu, L. and Simon, M. C. (2004) Regulation of transcription and translation by hypoxia. Cancer Biol. Ther. 3, 492-497
30. Anderson, G. R., Stoler, D. L. and Scarcello, L. A. (1989) Normal fibroblasts responding to anoxia exhibit features of the malignant phenotype. J. Biol. Chem. 264, 14885-14892
31. Cuvier, C., Jang, A. and Hill, R. P. (1997) Exposure to hypoxia, glucose starvation and acidosis: effect on invasive capacity of murine tumor cells and correlation with cathepsin (L + B) secretion. Clin. Exp. Metastasis 15, 19-25
32. Mukhopadhyay, D. and Dattab, K. (2004) Multiple regulatory pathways of vascular permeability factor/vascular endothelial growth factor (VPF/VEGF) expression in tumors. Semin. Cancer Biol. 14, 123-130
33. Dibbens, J. A., Miller, D. L., Damert, A., Risau, W., Vadas, M. A. and Goodall, G. J. (1999) Hypoxic regulation of vascular endothelial growth factor mRNA stability requires the cooperation of multiple RNA elements. Mol. Biol. Cell. 10, 907-919
34. Anderson, C. J., Hoare, S. F., Ashcroft, M., Bilsland, A. E. and Keith, W. N. (2006) Hypoxic regulation of telomerase gene expression by transcriptional and post-transcriptional mechanisms. Oncogene 25, 61-69
35. Romero-Ramirez, L., Cao, H., Nelson, D., Hammond, E., Lee, A. H., Yoshida, H., Mori, K., Glimcher, L. H., Denko, N. C., Giaccia, A. J. et al. (2004) XBP1 is essential for survival under hypoxic conditions and is required for tumor growth. Cancer Res. 64, 5943-5947
36. Felbor, U., Dreier, L., Bryant, R. A., Ploegh, H. L., Olsen, B. R. and Mothes, W. (2000) Secreted cathepsin L generates endostatin from collagen XVIII. EMBO J. 19, 1187-1194
37. Ohashi, K., Naruto, M., Nakaki, T. and Sano, E. (2003) Identification of interleukin-8 converting enzyme as cathepsin L. Biochim. Biophys. Acta 1649, 30-39
38. Liu, J. and Schwarz, M. A. (2006) Identification of protease-sensitive sites in Human Endothelial-Monocyte Activating Polypeptide II protein. Exp. Cell Res. 312, 2231-2237
39. Urbich, C., Heeschen, C., Aicher, A., Sasaki, K., Bruhl, T., Farhadi, M. R., Vajkoczy, P., Hofmann, W. K., Peters, C., Pennacchio, L. A. et al. (2005) Cathepsin L is required for endothelial progenitor cell-induced neovascularization. Nat. Med. 11, 206-213